CYTR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
CytRx Corp's quarterly cash and cash equivalents declined from Jun. 2013 ($10.98 Mil) to Sep. 2013 ($6.04 Mil) but then increased from Sep. 2013 ($6.04 Mil) to Dec. 2013 ($11.48 Mil).
CytRx Corp's annual cash and cash equivalents declined from Dec. 2011 ($17.99 Mil) to Dec. 2012 ($14.34 Mil) and declined from Dec. 2012 ($14.34 Mil) to Dec. 2013 ($11.48 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
CytRx Corp Annual Data
CytRx Corp Quarterly Data